Eliem Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eliem Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $400k | 31k | 13.04 |
| 2025-06-30 | $302 | 244 | 1.24 |
| 2025-03-31 | $21k | 17k | 1.22 |
| 2024-12-31 | $31k | 17k | 1.80 |
| 2024-09-30 | $67k | 13k | 5.09 |
| 2024-06-30 | $22k | 3.1k | 7.11 |
| 2024-03-31 | $137 | 50 | 2.74 |
| 2023-12-31 | $129 | 48 | 2.71 |
| 2023-09-30 | $117 | 45 | 2.62 |
| 2023-06-30 | $126 | 45 | 2.80 |
| 2022-12-31 | $154 | 42 | 3.67 |
| 2022-09-30 | $0 | 41 | 0.00 |
| 2022-06-30 | $0 | 44 | 0.00 |
| 2022-03-31 | $31k | 3.7k | 8.34 |
| 2021-12-31 | $67k | 6.4k | 10.43 |
| 2021-09-30 | $1.0k | 31 | 32.26 |